Keywords: Liver, Elastography, HCV, loss modulus, damping ratio
Motivation: While DAAs have significantly improved the treatment of HCV patients, some individuals still face relapse or progression. There is currently a deficiency in non-invasive and simple methods for effectively monitoring the longitudinal treatment effects.
Goal(s): To develop a reliable biomarker for detecting inflammatory response to DAA treatment in the early stages of HCV infection.
Approach: Longitudinal monitoring of changes in early-stage HCV patients after DAA treatment using multiparametric MRE.
Results: Multi-parameter MRE can detect HCV at the early stage and can monitor both short-term inflammatory response and long-term treatment effect of the liver in HCV patients after DAA treatment.
Impact: Developed a non-invasive biomarker for monitoring the efficacy of DAA treatment in early-stage HCV patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords